A public health expert explains why the United States is repeating the same mistake with the Hantavirus response as with COVID-19, particularly with communication and testing.
The physician shortage is real and worsening. Trusted and accessible pharmacists can help, and looking for business model to support the investment.
NVision raises $38 million led by health diagnostics giant Abbott to scale up its groundbreaking cancer imaging system. Next up: using its quantum technology to design new drugs.
Alignment Healthcare is bolstering its C-suite, adding the chairman’s role to CEO John Kao’s duties while promoting executives as the provider of Medicare Advantage grows.
Engineered exosomes that naturally go to brain and kidney cells can deliver gene‑silencing drugs far beyond the liver.
Forus reached $1 billion valuation by dealing with the unglamorous admin work of processing scrips so patients can get the drugs they need.
Dr. Omer Awan details lessons from COVID-19 that should be driving the U.S. response in order to contain the Andes hantavirus outbreak.
Jay Bhattacharya dismissed the test-negative design as ‘crap.’ The biostatistics literature tells a different story.
A nanobody that stabilizes mutant CFTR from inside the cell, especially when combined with existing drugs, restores near-normal function in cystic fibrosis cells.
Peptides have entered the menopause conversation, but growing interest in optimization and hormone health is also raising questions about safety & long-term evidence.